Synairgen Share Price | |
---|---|
Price | 6.49 |
Bid | 6.00 |
Ask | 6.98 |
Change | -0.10 (-1.52%) |
Volume | 203,677 |
Open | 6.59 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 6.59 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 201.37m |
Market Capitalisation | £13.27m |
Market Size | 30,000 |
52 Week High | 10.62 |
52 Week High Date | 29-Nov-2023 |
52 Week Low | 4.20 |
52 Week Low Date | 22-Mar-2024 |
# Trades | 16 |
---|---|
Vol. Sold | 178,275 |
Sold Value | £11.33k |
Vol. Bought | 25,402 |
Bought Value | £1.74k |
PE Ratio | -0.752283 |
Earnings | -8.76 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 16:29:41 | 6.21 | 20 | Sell* | 6.00 | 6.98 | 1.24 | O Ordinary |
26-Apr-24 | 16:27:13 | 6.21 | 27 | Sell* | 6.00 | 6.98 | 1.68 | O Ordinary |
26-Apr-24 | 15:37:44 | 6.74 | 13,560 | Buy* | 6.00 | 6.98 | 913.94 | O Ordinary |
26-Apr-24 | 14:53:07 | 6.30 | 7,383 | Sell* | 6.00 | 6.98 | 465.13 | O Ordinary |
26-Apr-24 | 14:51:18 | 6.21 | 917 | Sell* | 6.00 | 7.18 | 56.95 | O Ordinary |
26-Apr-24 | 14:49:31 | 6.90 | 1,250 | Buy* | 6.00 | 7.18 | 86.25 | O Ordinary |
26-Apr-24 | 14:08:37 | 6.311 | 13,643 | Sell* | 6.00 | 7.18 | 861.01 | O Ordinary |
26-Apr-24 | 12:41:03 | 6.35 | 85,000 | Sell* | 6.00 | 7.18 | 5,398 | O Ordinary |
26-Apr-24 | 11:56:28 | 6.311 | 3,000 | Sell* | 6.00 | 7.18 | 189.33 | O Ordinary |
26-Apr-24 | 10:13:08 | 6.415 | 25,000 | Sell* | 6.00 | 7.18 | 1,604 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.42 | GBX | 621 | 8,520 |
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.74 | GBX | 7,899 | 8,520 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | John C Ward held the position of Finance Director at the time of this trade.John C Ward | 1.00 | GBX | 489,148 | 734,092 |
12-Aug-21 | 12-Aug-21 | Sell | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 140.00 | GBX | 220,878 | 423,934 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 1.00 | GBX | 400,212 | 423,934 |
Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.